CMC - Lead to Intervacc

At Intervacc, we are pioneering the next generation of veterinary vaccines through our proprietary technology platform. Rooted in

research from the Karolinska Institute (KI) and the Swedish University of Agricultural Sciences (SLU), our mission is to reduce

the impact of bacterial infections in animals through innovative, effective, and safe vaccines.

Our first proprietary product — a vaccine against strangles, a serious streptococcal infection in horses— is now available in

several European markets. This is just the beginning. We are expanding our reach into new territories and broadening our product

portfolio.

We have an exciting new opportunity for an experienced CMC Lead who will be responsible for the manufacturing and testing for the

company’s marketed products, as well as the CMC-strategy for development of new vaccine products. The CMC Lead will have a central

role in providing scientific guidance, support, and expertise for all CMC activities including commercial products and product

under development. You will work with products in different markets to fulfill a key role within our dedicated, friendly and

experienced team. If this sounds interesting to you – come join us!

Intervacc AB is headquartered in Stockholm Sweden and is listed on the Swedish Nasdaq First North Growth Market. The position is

full-time, and we welcome your application today!

As a CMC Lead, you will provide CMC strategy and expertise for our development and marketed products to ensure the company’s

products are developed, manufactured, tested and maintained in compliance with global regulatory expectations, requirements and

guidance.

• Responsibility of delivering CMC-parts of development projects, launch projects as well as projects/products in commercial

phase

• Developing CMC-strategies and ensuring oversight and planning of work performed at CROs/CMOs related to development, analytical

testing and manufacturing of products

• Being responsible and promote using modern processing analytical principles such as Quality by Design, risk-based method

development and data-driven decision making.

• Working with other internal functions as well as external suppliers and partners to ensure CMC-deliverables and resolve arising

issues

• Significant experience (more than 7-10 years) in development, manufacturing and analytical testing of biologics or

biotechnology-derived products e.g. vaccines from the pharmaceutical industry

• Significant knowledge of the drug development and manufacturing process for biologics (including upstream and downstream

processes and analytical methods)

• Knowledge of current regulatory CMC requirements, and solid knowledge in understanding of regulations and guidance for the

manufacturing of biotechnology products

• Has a solid scientific background with significant experience in processing and analytical testing of biotechnology products in

combination with project management skills

If you are ready to bring your expertise within the CMC area for biologics, we are ready to offer you an excellent career

opportunity at an innovative company with an exciting journey ahead!

Intervacc is an innovative Swedish biotechnology company that develops and markets modern, effective, and safe vaccines against

bacterial infections affecting animals. Over the past decade, advances in molecular biology techniques have significantly enhanced

our ability to investigate the genomes of pathogenic bacteria. Building on our research foundations at the Karolinska Institute

(KI) and the Swedish University of Agricultural Sciences (SLU), we have developed a technology platform for a new generation of

vaccines. Our first proprietary vaccine, a vaccine against the streptococcal infection strangles, which affects horses—is now

available in several European markets. The Intervacc share (STO: IVACC) is listed on the NASDAQ First North Growth Market and our

headquarter is in Stockholm, Sweden. You can find more information about Intervacc at www.intervacc.se